[Animal disease models of labyrinth diseases].
D000617:Aminoglycosides / Q000008:administration & dosage / Q000633:toxicity; D000818:Animals; D000970:Antineoplastic Agents / Q000633:toxicity; D003051:Cochlea / Q000033:anatomy & histology / Q000187:drug effects / Q000473:pathology; D006224:Cricetinae; D003638:Deafness / Q000473:pathology; D004195:Disease Models, Animal; D004232:Diuretics / Q000008:administration & dosage / Q000633:toxicity; D007758:Ear, Inner / Q000033:anatomy & histology; D006801:Humans; D007759:Labyrinth Diseases / Q000473:pathology*; D051379:Mice; D010812:Physical Stimulation; D011817:Rabbits; D051381:Rats
D000617:Aminoglycosides; D000970:Antineoplastic Agents; D004232:Diuretics